PF-Atlas › Clinical Trials › NCT03659578
Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer
Concurrent chemotherapy · Phase 2
Registry ID
NCT03659578
Phase
Phase 2
Status
Completed
Drug / intervention
Concurrent chemotherapy
Sponsor
Sun Yat-sen University
Start
2018-08-09
Enrollment
69
Locations
1
About this trial
This Phase II study is to determine the efficacy of Thymosin α1 on the frequency of acute pneumonia in non-small cell lung cancer with bulky tumor.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT03659578 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.